1. Home
  2. INTZ vs MRKR Comparison

INTZ vs MRKR Comparison

Compare INTZ & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$1.12

Market Cap

21.3M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

N/A

Current Price

$1.37

Market Cap

23.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INTZ
MRKR
Founded
1983
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3M
23.0M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
INTZ
MRKR
Price
$1.12
$1.37
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$7.25
$11.25
AVG Volume (30 Days)
139.9K
117.5K
Earning Date
04-28-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
85.78
33.61
EPS
N/A
N/A
Revenue
$5,771,000.00
N/A
Revenue This Year
$35.44
N/A
Revenue Next Year
$23.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$0.75
$0.81
52 Week High
$2.64
$4.07

Technical Indicators

Market Signals
Indicator
INTZ
MRKR
Relative Strength Index (RSI) 52.97 42.58
Support Level $0.81 $0.83
Resistance Level $1.17 $1.44
Average True Range (ATR) 0.11 0.10
MACD 0.01 0.00
Stochastic Oscillator 42.35 30.00

Price Performance

Historical Comparison
INTZ
MRKR

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: